Stephens & Co. Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
iRhythm Holdings, Inc IRTC
$117.17
▼ -1.60%
($-1.91)
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$117.49
Prev Close
$119.08
Day Range
$116.50 – $120.11
52W Range
$100.85 – $212.00
Market Cap
$3.85B
Beta
1.32
EPS (TTM)
$-0.86
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-10-20 |
| Shares Out. | 32,860,000 |
| Website | irhythmtech.com/ ↗ |
| Phone | 16506325700 |
| Employees | 2,400 |
| Revenue | $199.4M |
| Gross Profit | $141.4M |
| Net Income | -$13.9M |
| Free Cash Flow | $18.8M |
| Total Assets | $1.01B |
| Total Liabilities | $845.2M |
| Equity | $161.2M |
About iRhythm Holdings, Inc
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
iRhythm Holdings, Inc is a publicly traded company under the ticker symbol IRTC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-07-01)